CLLS
Price
$1.14
Change
-$0.06 (-5.00%)
Updated
Apr 4, 04:57 PM (EDT)
Capitalization
168.42M
31 days until earnings call
SLN
Price
$2.60
Change
-$0.14 (-5.11%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
120.42M
Ad is loading...

CLLS vs SLN

Header iconCLLS vs SLN Comparison
Open Charts CLLS vs SLNBanner chart's image
Cellectis SA
Price$1.14
Change-$0.06 (-5.00%)
Volume$214
Capitalization168.42M
Silence Therapeutics
Price$2.60
Change-$0.14 (-5.11%)
Volume$862
Capitalization120.42M
CLLS vs SLN Comparison Chart
Loading...
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLLS vs. SLN commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLLS is a Buy and SLN is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 07, 2025
Stock price -- (CLLS: $1.20 vs. SLN: $2.74)
Brand notoriety: CLLS and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLLS: 26% vs. SLN: 45%
Market capitalization -- CLLS: $168.42M vs. SLN: $120.42M
CLLS [@Biotechnology] is valued at $168.42M. SLN’s [@Biotechnology] market capitalization is $120.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLLS’s FA Score shows that 1 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • CLLS’s FA Score: 1 green, 4 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, both CLLS and SLN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLLS’s TA Score shows that 5 TA indicator(s) are bullish while SLN’s TA Score has 3 bullish TA indicator(s).

  • CLLS’s TA Score: 5 bullish, 2 bearish.
  • SLN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CLLS is a better buy in the short-term than SLN.

Price Growth

CLLS (@Biotechnology) experienced а -7.69% price change this week, while SLN (@Biotechnology) price change was -25.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.75%. For the same industry, the average monthly price growth was -16.58%, and the average quarterly price growth was -18.37%.

Reported Earning Dates

CLLS is expected to report earnings on May 07, 2025.

SLN is expected to report earnings on May 14, 2024.

Industries' Descriptions

@Biotechnology (-10.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLLS($168M) has a higher market cap than SLN($120M). CLLS YTD gains are higher at: -33.333 vs. SLN (-60.174). CLLS has higher annual earnings (EBITDA): -9.46M vs. SLN (-48.99M). CLLS has more cash in the bank: 260M vs. SLN (147M). SLN has less debt than CLLS: SLN (117K) vs CLLS (91.5M). SLN (43.3M) and CLLS (41.5M) have equivalent revenues.
CLLSSLNCLLS / SLN
Capitalization168M120M140%
EBITDA-9.46M-48.99M19%
Gain YTD-33.333-60.17455%
P/E RatioN/AN/A-
Revenue41.5M43.3M96%
Total Cash260M147M177%
Total Debt91.5M117K78,205%
FUNDAMENTALS RATINGS
CLLS: Fundamental Ratings
CLLS
OUTLOOK RATING
1..100
1
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLLSSLN
RSI
ODDS (%)
Bullish Trend 6 days ago
85%
Bullish Trend 6 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 6 days ago
85%
Momentum
ODDS (%)
Bullish Trend 6 days ago
72%
Bearish Trend 6 days ago
86%
MACD
ODDS (%)
Bullish Trend 6 days ago
78%
Bearish Trend 6 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
77%
Bearish Trend 6 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
70%
Bearish Trend 6 days ago
85%
Advances
ODDS (%)
Bullish Trend 14 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 6 days ago
88%
Aroon
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 6 days ago
79%
View a ticker or compare two or three
Ad is loading...
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X83102.830000617.109400
+0.75%
Bitcoin cryptocurrency
SPY536.70-27.82
-4.93%
SPDR® S&P 500® ETF Trust
TSLA267.28-15.48
-5.47%
Tesla
GME21.10-1.59
-7.01%
GameStop Corp
AAPL203.19-20.70
-9.25%
Apple

CLLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLLS has been loosely correlated with SLN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CLLS jumps, then SLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLLS
1D Price
Change %
CLLS100%
-4.76%
SLN - CLLS
43%
Loosely correlated
-5.19%
PMVP - CLLS
39%
Loosely correlated
-0.50%
TGTX - CLLS
36%
Loosely correlated
-1.21%
CLGN - CLLS
33%
Poorly correlated
-4.52%
DTIL - CLLS
32%
Poorly correlated
+0.43%
More

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
-5.19%
CLLS - SLN
43%
Loosely correlated
-4.76%
RCKT - SLN
38%
Loosely correlated
-11.75%
NTLA - SLN
34%
Loosely correlated
-5.62%
GBIO - SLN
33%
Poorly correlated
+7.37%
PCVX - SLN
32%
Poorly correlated
-9.29%
More